Axon Enterprise AXON
$ 627.62
1.94%
Annual report 2023
added 02-27-2024
Country |
USA |
IPO year |
- |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBALSPB |
CEO |
- |
Employees in the company |
1 323 |
Shares |
74.2 M |
Market Cap[1] |
$ 46.6 B |
EBITDA (LTM) |
$ 112 M |
P/E (LTM) |
124.17 |
P/S (LTM) |
10.71 |
EPS (LTM) |
1.75 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.